Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Methods × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Breast 5 Gynecologic 3 Genitourinary 3 Tumor-Agnostic 2 Other 2 Head & Neck 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma 1

Interventions

Rituximab 429 Cyclophosphamide 349 Vincristine 179 Doxorubicin 156 Etoposide 141 fludarabine phosphate 135 Prednisone 135 fludarabine 130 Cytarabine 126 Methotrexate 125 Dexamethasone 102 Lenalidomide 99 Filgrastim 99 Granulocyte Colony-Stimulating Factor 92 Whole-Body Irradiation 84 ibrutinib 78 Mycophenolic Acid 76 Bendamustine Hydrochloride 72 Calcium Dobesilate 69 Melphalan 68 Bortezomib 65 Busulfan 62 Tacrolimus 61 Peripheral Blood Stem Cell Transplantation 57 obinutuzumab 54 Radiotherapy 49 ofatumumab 46 Antilymphocyte Serum 45 Cyclosporine 44 Brentuximab Vedotin 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡